Larry Mathis Financial Planning’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$252K Sell
13,846
-787
-5% -$13.9K 0.21% 95
2026
Q2
$235K Buy
14,633
+446
+3% +$7.38K 0.18% 126
2026
Q1
$263K Sell
14,187
-156
-1% -$2.74K 0.24% 122
2025
Q4
$224K Buy
+14,343
New +$205K 0.2% 140

Other funds holding TAK

Larry Mathis Financial Planning's TAK Position: Q3 2026 in Review

Larry Mathis Financial Planning reduced its Takeda Pharmaceutical (TAK) stake by 5.4% in Q3 2026, selling an estimated $13.9K and leaving 13,846 shares worth $252K. The position accounts for 0.21% of the portfolio, ranked #95.

Larry Mathis Financial Planning first reported a position in TAK in Q4 2025 and has held it in 4 quarters since. The position peaked at $263K in Q1 2026. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Larry Mathis Financial Planning held 13,846 shares of Takeda Pharmaceutical worth $252K as of Q3 2026.
  • Larry Mathis Financial Planning sold 787 Takeda Pharmaceutical shares in Q3 2026, an estimated $13.9K.
  • Takeda Pharmaceutical made up 0.21% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #95 holding.
  • Larry Mathis Financial Planning first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • Larry Mathis Financial Planning's Takeda Pharmaceutical position peaked at $263K in Q1 2026.
  • 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.